María Pilar
Garrido López
Profesor/a Asociado/a en CC. de la Salud
Clínica Universitaria de Navarra
Pamplona, EspañaClínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2024
-
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer
Lung Cancer, Vol. 197
-
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789
2023
-
Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2022), 25, 5, (1252-1267), 10.1007/s12094-022-03046-9)
Clinical and Translational Oncology